SBI Okasan Asset Management »

Denali Therapeutics shares owned by SBI Okasan Asset Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by SBI Okasan Asset Management from 13F filings

Historical chart of SBI Okasan Asset Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by SBI Okasan Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by SBI Okasan Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $533k 30k 18.08

More positions owned by SBI Okasan Asset Management

Vanguard Total Stock Mkt Etf Total Stk Mkt (VTI)
Ishr Ibx Usd Hiyld Cb Etf-ui Iboxx Hi Yd Etf (HYG)
Ishares Jp Morgan Usd Emergi Jpmorgan Usd Emg (EMB)
Vanguard Ftse Developed Etf Van Ftse Dev Mkt (VEA)
Spdr Gold Minishares Trust Spdr Gld Minis (GLDM)
Vanguard Ftse Emerging Marke Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation (NVDA)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Ishares Semiconductor Etf Ishares Semicdtr (SOXX)
Apple (AAPL)
Tesla Motors (TSLA)
Amazon (AMZN)
Ss Technology Select Sector State Street Tec (XLK)
Broadcom (AVGO)

View all positions for SBI Okasan Asset Management

Top funds holding Denali Therapeutics

Vanguard Group
BlackRock
Baillie Gifford & Co
T. Rowe Price Investment Management
Temasek Holdings
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
FMR
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Geode Capital Management
Holocene Advisors
Alliancebernstein

View all funds holding Denali Therapeutics